0      0

AONN+ Midyear 2022

FRI09 - Explore data for an FDA-approved treatment option in HR+, HER2- breast cancer in certain adjuvant or metastatic settings| Presentation by Lilly Oncology

May 13, 2022 2:15pm ‐ May 13, 2022 3:15pm



You must be logged in and own this session in order to post comments.